ANL 13.60 Decreased By ▼ -0.20 (-1.45%)
ASC 14.90 Increased By ▲ 0.34 (2.34%)
ASL 15.35 Increased By ▲ 0.05 (0.33%)
AVN 97.75 Decreased By ▼ -2.14 (-2.14%)
BOP 8.64 Increased By ▲ 0.04 (0.47%)
CNERGY 6.80 Decreased By ▼ -0.21 (-3%)
FFL 9.35 Decreased By ▼ -0.14 (-1.48%)
FNEL 9.21 Decreased By ▼ -0.18 (-1.92%)
GGGL 14.57 Decreased By ▼ -0.33 (-2.21%)
GGL 22.00 Decreased By ▼ -0.12 (-0.54%)
GTECH 9.81 Decreased By ▼ -0.16 (-1.6%)
HUMNL 6.67 Increased By ▲ 0.01 (0.15%)
KEL 3.22 Decreased By ▼ -0.04 (-1.23%)
KOSM 4.25 Decreased By ▼ -0.13 (-2.97%)
MLCF 33.50 Decreased By ▼ -0.54 (-1.59%)
PACE 4.29 Decreased By ▼ -0.06 (-1.38%)
PIBTL 7.33 Decreased By ▼ -0.07 (-0.95%)
PRL 14.75 Decreased By ▼ -0.15 (-1.01%)
PTC 9.00 Decreased By ▼ -0.10 (-1.1%)
SILK 1.39 Decreased By ▼ -0.02 (-1.42%)
SNGP 34.25 Decreased By ▼ -0.25 (-0.72%)
TELE 18.23 Increased By ▲ 0.48 (2.7%)
TPL 15.06 Decreased By ▼ -0.29 (-1.89%)
TPLP 29.47 Decreased By ▼ -0.43 (-1.44%)
TREET 40.30 Decreased By ▼ -0.71 (-1.73%)
TRG 91.99 Decreased By ▼ -2.36 (-2.5%)
UNITY 27.56 Decreased By ▼ -0.64 (-2.27%)
WAVES 15.35 Decreased By ▼ -0.18 (-1.16%)
WTL 2.32 Decreased By ▼ -0.03 (-1.28%)
YOUW 8.00 Decreased By ▼ -0.22 (-2.68%)
BR100 4,651 Decreased By -26.8 (-0.57%)
BR30 18,308 Decreased By -316 (-1.7%)
KSE100 45,287 Decreased By -220.1 (-0.48%)
KSE30 17,830 Decreased By -95.8 (-0.53%)

coronavirus
Coronavirus
VERY HIGH
Source: covid.gov.pk
Pakistan Deaths
29,037
824hr
Pakistan Cases
1,338,993
5,47224hr
Sindh
509,308
Punjab
455,499
Balochistan
33,744
Islamabad
112,557
KPK
182,619

TOKYO: US drugmaker Pfizer Inc said on Friday it has applied for Japanese government approval for its oral COVID-19 treatment.

The application is based on global Phase II/III trials that Japan was part of, Pfizer said in a statement.

With COVID-19 cases surging again, Japan is betting heavily on oral treatments to keep serious infections and deaths at bay.

Pfizer to cut US sales staff as meetings with healthcare providers move to virtual

Prime Minister Fumio Kishida said last week he aimed to distribute the Pfizer pills next month after securing 2 million doses during a December call with Chief Executive Albert Bourla.

The government has already started distributing molnupiravir antiviral pills after agreeing to pay Merck & Co Inc and its partner Ridgeback Biotherapeutics about $1.2 billion for 1.6 million courses. Japan's Shionogi & Co Ltd is working on its own pill, with plans to supply 1 million doses this year.

The highly infectious Omicron variant is driving a surge in COVID-19 cases. Japan recorded 18,859 new infections on Thursday, according to a tally by national broadcaster NHK, the most since Sept. 2 during what was the country's fifth wave of the pandemic.

Comments

1000 characters